Tag Archives: panel

FDA advisory panel split over Sanofi-Lexicon diabetes drug

(Reuters) – An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France’s Sanofi SA. The panel on Thursday voted 8-8 when asked to assess the once-daily oral medicine, sotagliflozin, an add-on to insulin therapy.… Read More »